Secondly, loss of PTEN and the consequent activation of the PI3K pathway renders T-ALL cells less dependent on NOTCH1 signaling for their growth and proliferation, and thus GSI therapy turns out to be less effective [108]. This evidence concerns the gene PTEN and acute lymphoblastic leukemia.